Competing interests
Cancer
CANCER
GR received research support from Pfizer and served on the speaker bureau for Bristol Myers Squibb, Incyte, Novartis, and Pfizer. THB provides consultancy to Janssen, Merck, Novartis, Pfizer, and Takeda, and received research support from Novartis and Pfizer. BTG provides consultancy to BerGenBio, Novartis, Pfizer, and Sanofi, received research support from Pfizer, and has stock ownership in Alden Cancer Therapy AS and KinN Therapeutics AS. PG-C received research support from Bristol Myers Squibb and Pfizer. FC provides consultancy to and received honoraria from Bristol Myers Squibb, Incyte, Novartis, and Pfizer, and received research support from Pfizer. CG-P provides consultancy to Bristol Myers Squibb and received honoraria and research support from Pfizer. TE, no relationships to disclose. HZ, LK, and SP are employees of Pfizer. FJG provided consultancy to Actuate Therapeutics Inc, provided expert testimony to Novartis, and received research support from Pfizer. AH received research support from Bristol Myers Squibb, Incyte, Novartis, and Pfizer.